Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

2 terminated/withdrawn out of 12 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

86%

6 of 7 completed trials have results

Key Signals

1 recruiting6 with results

Enrollment Performance

Analytics

N/A
11(100.0%)
11Total
N/A(11)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)